These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 18824906

  • 1. Early intravenous unfractionated heparin and mortality in septic shock.
    Zarychanski R, Doucette S, Fergusson D, Roberts D, Houston DS, Sharma S, Gulati H, Kumar A.
    Crit Care Med; 2008 Nov; 36(11):2973-9. PubMed ID: 18824906
    [Abstract] [Full Text] [Related]

  • 2. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC, Portuguese Community-Acquired Sepsis Study Group.
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [Abstract] [Full Text] [Related]

  • 3. Activated protein C and septic shock: a propensity-matched cohort study*.
    Rimmer E, Kumar A, Doucette S, Marshall J, Dial S, Gurka D, Dellinger RP, Sharma S, Penner C, Kramer A, Wood K, Ronald J, Kumar A, Turgeon AF, Houston DS, Zarychanski R, Co-operative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group.
    Crit Care Med; 2012 Nov; 40(11):2974-81. PubMed ID: 22932397
    [Abstract] [Full Text] [Related]

  • 4. Low-dose corticosteroid treatment in septic shock: a propensity-matching study.
    Funk D, Doucette S, Pisipati A, Dodek P, Marshall JC, Kumar A, Cooperative Antimicrobial Therapy of Septic Shock Database Research Group.
    Crit Care Med; 2014 Nov; 42(11):2333-41. PubMed ID: 25072758
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Current practice in nutritional support and its association with mortality in septic patients--results from a national, prospective, multicenter study.
    Elke G, Schädler D, Engel C, Bogatsch H, Frerichs I, Ragaller M, Scholz J, Brunkhorst FM, Löffler M, Reinhart K, Weiler N, German Competence Network Sepsis (SepNet).
    Crit Care Med; 2008 Jun; 36(6):1762-7. PubMed ID: 18496367
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Before-after study of a standardized hospital order set for the management of septic shock.
    Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, Murphy T, Prentice D, Ruoff BE, Kollef MH.
    Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733
    [Abstract] [Full Text] [Related]

  • 13. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF, Nogueira de Sá FR, Oliveira DS, Gottschald AF, Moura JD, Shibata AR, Troster EJ, Vaz FA, Carcillo JA.
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [Abstract] [Full Text] [Related]

  • 14. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients.
    Raurich JM, Llompart-Pou JA, Ibáñez J, Frontera G, Pérez O, García L, Ayestarán JI.
    J Crit Care; 2007 Dec; 22(4):324-9. PubMed ID: 18086404
    [Abstract] [Full Text] [Related]

  • 15. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock.
    de Jong MF, Beishuizen A, Spijkstra JJ, Groeneveld AB.
    Crit Care Med; 2007 Aug; 35(8):1896-903. PubMed ID: 17568326
    [Abstract] [Full Text] [Related]

  • 16. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study.
    Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, De Backer D, Payen D.
    Crit Care Med; 2006 Mar; 34(3):589-97. PubMed ID: 16505643
    [Abstract] [Full Text] [Related]

  • 17. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, Watson D, Grossman S, Donaldson J, Takala J, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
    [Abstract] [Full Text] [Related]

  • 18. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin.
    Arch Intern Med; 1994 Nov 14; 154(21):2484-91. PubMed ID: 7979845
    [Abstract] [Full Text] [Related]

  • 19. The current management of septic shock.
    Russel JA.
    Minerva Med; 2008 Oct 14; 99(5):431-58. PubMed ID: 18971911
    [Abstract] [Full Text] [Related]

  • 20. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J.
    Crit Care Med; 2007 Aug 14; 35(8):1888-95. PubMed ID: 17581492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.